191 related articles for article (PubMed ID: 5346123)
1. [Results of the Tranquo-Alupent test in patients with chronic asthmatoid bronchitis].
Schildwächter G; Böhlau V
Med Monatsschr; 1969 Oct; 23(10):459-61. PubMed ID: 5346123
[No Abstract] [Full Text] [Related]
2. [Effect of Tranquo-Alupent in asthmatic syndrome].
Gentschy E; Ott N
Ther Ggw; 1969 Sep; 108(9):1298 passim. PubMed ID: 4910102
[No Abstract] [Full Text] [Related]
3. [Therapy of the asthmatic syndrome with the new combination preparation Tranquo-Alupent].
Boriss W; Lampe W
Med Monatsschr; 1968 Jan; 22(1):28-30. PubMed ID: 5707444
[No Abstract] [Full Text] [Related]
4. The bronchodilator effects of orciprenaline and salbutamol. A double-blind study.
Racoveanu C; Stanescu DC; Manicatide M; Stroescu V
Postgrad Med J; 1971 Mar; 47():Suppl:83-6. PubMed ID: 4929399
[No Abstract] [Full Text] [Related]
5. [Controlled therapeutic comparison of antiasthmatics in out-patients in a double-blind experiment].
Lichterfeld A
Arzneimittelforschung; 1967 Oct; 17(10):1318-21. PubMed ID: 4885304
[No Abstract] [Full Text] [Related]
6. [On the therapy of asthmatic dyspnea].
Kann J; Jokl H
Med Klin; 1968 Nov; 63(45):1814-8. PubMed ID: 5706199
[No Abstract] [Full Text] [Related]
7. [The use of a new bronchodynamic drug by aerosol administration in asthmatic bronchitis and emphysema patients. Study of the respiratory function].
Cardaci G; Vittore F; Bussa B
Clin Ter; 1968 Jun; 44(6):533-41. PubMed ID: 5736873
[No Abstract] [Full Text] [Related]
8. [Clinical experiences with a new beta 2-receptor stimulant in spastic lung diseases in pediatrics].
Starnegg Q
Wien Med Wochenschr; 1971 May; 121(22):455-7. PubMed ID: 5092121
[No Abstract] [Full Text] [Related]
9. [Observations on the use of a sympathomimetic aerosol for diagnostic and therapeutic use].
Gaffuri E; Reggiani A
Clin Ter; 1967 Dec; 43(6):559-65. PubMed ID: 5617981
[No Abstract] [Full Text] [Related]
10. [Salbutamol as a beta-adrenergic stimulator in bronchospastic pulmonary conditions].
Dano P; Falholt W
Ugeskr Laeger; 1971 Apr; 133(15):685-8. PubMed ID: 4396922
[No Abstract] [Full Text] [Related]
11. [Comparative study of the action of beta-sympathomimetic bronchodilator agents in chronic obstructive pneumopathy].
Racoveanu C; Manicatide M
Stud Cercet Med Interna; 1971; 12(2):151-60. PubMed ID: 5565346
[No Abstract] [Full Text] [Related]
12. [The influence of orciprenaline on circulation in the lung].
Daum S; Stiksa J; Nikodýmová L; Petrle A; Svorcik C
Arzneimittelforschung; 1967 May; 17(5):565-8. PubMed ID: 5631585
[No Abstract] [Full Text] [Related]
13. The bronchodilator effects of orciprenaline and salbutamol: a double-blind study.
Racoveanu C; Stanescu DC; Manicatide M; Stroescu V
Bull Physiopathol Respir (Nancy); 1970; 6(4):809-18. PubMed ID: 4940888
[No Abstract] [Full Text] [Related]
14. Comparison of the effects of salbutamol and orciprenaline in asthma.
Dano P
Postgrad Med J; 1971 Mar; 47():Suppl:86-8. PubMed ID: 4929400
[No Abstract] [Full Text] [Related]
15. [Changes in respiration function in patients with bronchial asthma and asthmatic bronchitis after a single administration of alupent aerosol].
Nefedov VB; Kublashvili GG
Ter Arkh; 1971 Mar; 43(3):44-8. PubMed ID: 5561195
[No Abstract] [Full Text] [Related]
16. Bronchodilator action of drug combinations in asthmatic patients: decloxizine, orciprenaline, and ephedrine.
Muittari A; Mattila MJ; Patiala J
Ann Allergy; 1969 Jun; 27(6):274-9. PubMed ID: 4891707
[No Abstract] [Full Text] [Related]
17. [Experiences with a complex asthma therapy].
Messerich J
Ther Ggw; 1967 Dec; 106(12):1601-2 passim. PubMed ID: 5622113
[No Abstract] [Full Text] [Related]
18. [Study of the bronchodilating action of Th 152].
Hervê I; Pavani LM
Hospital (Rio J); 1966 Sep; 70(3):749-58. PubMed ID: 5300282
[No Abstract] [Full Text] [Related]
19. The combined action of broncholytic agents in asthmatic patients: orciprenaline, isoprenaline, and ephedrine.
Muittari A; Mattila MJ; Tiitinen H
Ann Med Intern Fenn; 1968; 57(1):31-5. PubMed ID: 4882181
[No Abstract] [Full Text] [Related]
20. Effect of bronchodilator drugs on the peak expiratory flow rate of asthmatic patients: oral orciprenaline and terbutaline (KWD 2019).
Mattila MJ; Muittari A
Ann Med Exp Biol Fenn; 1969; 47(4):298-302. PubMed ID: 4911261
[No Abstract] [Full Text] [Related]
[Next] [New Search]
